| scholarly article | Q13442814 |
| P2093 | author name string | Fa-Xing Yu | |
| Kang Zhang | |||
| Kun-Liang Guan | |||
| Hong Ouyang | |||
| Vera Lyubasyuk | |||
| P2860 | cites work | Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling | Q24294906 |
| Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP | Q24298571 | ||
| Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP | Q24594281 | ||
| Mutations in GNA11 in uveal melanoma | Q24625723 | ||
| Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. | Q33819083 | ||
| Uveal melanoma: epidemiologic aspects | Q34555934 | ||
| Mutational profile of GNAQQ209 in human tumors. | Q37313504 | ||
| The Hippo pathway: regulators and regulations | Q38083640 | ||
| The neural crest origin of uveal melanomas | Q70110771 | ||
| P433 | issue | 1 | |
| P304 | page(s) | e970957 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Molecular & cellular oncology | Q27725948 |
| P1476 | title | YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutations | |
| P478 | volume | 2 |
| Q92488138 | Direct targeting of Gαq and Gα11 oncoproteins in cancer cells |
| Q47223959 | Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas. |
| Q52726945 | Hippo-yap signaling in ocular development and disease. |
| Q48543754 | Subcutaneous melanocytoma mimicking a lipoma: a rare presentation of a rare neoplasm with histological, immunohistochemical, cytogenetic and molecular characterization |
| Q92880008 | Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives |
| Q37742632 | The biology of uveal melanoma |
| Q47180702 | Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer. |
| Q36353186 | Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity |
| Q89393034 | Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation |
Search more.